Effects of reserpine treatment on the dopamine receptor binding of [3H/11C]nemonapride in the mouse and rat brain

Annals of Nuclear Medicine

Volumn 11, Issue 1, 1997, Pages 21-26

  Ishiwata, Kiichi ^a   Onoguchi, Kaori ^a   Toyama, Hinako ^a   Noguchi, Junko ^a   Senda, Michio ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

ex vivo autoradiography; reserpine

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; EMONAPRIDE; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MEMBRANE BINDING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STRIATE CORTEX;

EID: 0030933973     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164753     Document Type: Article

References (34)

1. Wagner HN, Burns HD, Dannals RF, Wong DF, Langstrom B, Duelfer T, et al. Imaging dopamine receptors in the human brain by positron emission tomography. Science 221: 1264-1266, 1983.
2. Mazière M, Coenen HH, Halldin C, Någren K, Pike VW. PET radioligands for dopamine receptors and re-uptake sites: Chemistry and biochemistry. Nucl Med Biol 19: 497-512, 1992.
3. Sawle GV, Brooks DJ. Positron emission tomography studies of neurotransmitter systems. J Neurol 237: 451-456, 1990.
4. Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of dopamine-D2 receptor binding in the living human brain by positron emission tomography. Science 231: 258-261, 1986.
5. Seeman P, Guan HC, Van Tol HHM. Dopamine D4 receptors elevated in schizophrenia. Nature 365: 441-445, 1993.
6. 3H]raclopride: implications for positron emission tomography of the human brain. Synapse 3: 96-97, 1989.
7. 3H]raclopride in the mouse brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 340: 6-12, 1989.
8. 3H]raclopride binding in the rat brain. Synapse 9: 188-194, 1991.
9. 3H]raclopride in reserpine-treated mouse brain. J Neural Transm 85: 1-10, 1991.
10. 3H]raclopride binding to homogenates from human putamen and accumbens. Neurosci Lett 136: 79-82, 1992.
11. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier G, et al. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12: 47-54, 1992.
12. 2 receptors. CYRIC Annual Reports, Tohoku University 1986: 164-170, 1986.
13. 2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2. J Nucl Med 30: 515-522, 1989.
14. Hatazawa J, Hatano K, Ishiwata K, Itoh M, Ido T, Kawashima K, et al. Measurement of D2 dopamine receptor-specific carbon-11-YM-01951-2 binding in the canine brain by PET: Importance of partial volume correction. J Nucl Med 32: 713-718, 1991.
15. Hatazawa J, Ido T, Watabe K, Itoh M, Iwata R, Ishiwata K, et al. Age dependency in central dopamine D2 receptor specific and non-specific binding of [C-11]YM-09151-2. J Nucl Med 33: 897, 1992.
16. 2 receptors assessed in vivo and ex vivo for metabolic modeling in PET studies. J Neural Transm 97: 119-133, 1994.
17. Itoh M, Yamaguchi S, Meguro K, Fujiwara T, Iwata R, Ido T, et al. Neuroreceptor PET; Assessment of dopamine neurotransmission in dementia. In Brain, heart and tumor imaging. Updated PET and MRI. Ochi H, et al. (ed.), Elsevier Science B.V., pp. 101-105, 1995.
18. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614, 1991.
19. 3H]nemonapride. J Neurochem 64: 1413-1415, 1995.
20. 2-dopaminergic receptors. Jpn J Pharmacol 33: 749-755, 1983.
21. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur J Pharmacol 173: 177-182, 1989.
22. 11C]semotiadil, a benzothiazine calcium antagonist. Appl Radiat Isot 45: 439-443, 1994.
23. 3H]neuroleptic binding. Eur J Pharmacol 144: 163-171, 1987.
24. 2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human positron emission tomography. Eur J Pharmacol 227: 139-146, 1992.
25. Chivers JK, Gommeren W, Leysen JE, Jenner P, Marsden CD. Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. J Pharm Pharmacol 40: 415-421, 1988.
26. Fujiwara Y, Tomita H, Hikiji M, Kashihara K, Otsuki S, Ohnuki T, et al. Characterization of a cloned rat serotonin 5-HT1A receptor expressed in the HeLa cell line. Life Sci 52: 949-958, 1993.
27. 125I]epidepride. Eur J Pharmacol 286: R3-R5, 1995.
28. Murray AM, Hyde TM, Knabel MB, Herman MM, Bigelow LB, Carter JM, et al. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15: 2186-2191, 1995.
29. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res 681: 109-116, 1995.
30. 4 receptors in drug-treated schizophrenia. Eur J Pharmacol 281: R5-R6, 1995.
31. Reynolds GP. Dopamine D4 receptors schizophrenia? J Neurochem 66: 881-882, 1996.
32. 2 dopamine receptors in drug-naive schizophrenics. Science 234: 1558-1563, 1986.
33. 2 dopamine receptors in neurolepticnaive schizophrenic patients. Arch Gen Psychiatry 47: 213-219, 1990.
34. 11C]NMSP. Psychiatry Res 61: 67-83, 1995.